SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.

SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.
复制标题

DOI:
10.1093/infdis/jiab368
复制
发表时间:
2021-09-17
期刊:
The Journal of infectious diseases
影响因子:
--
通讯作者:
Genotype to Phenotype Japan (G2P-Japan) Consortium
Genotype to Phenotype Japan (G2P-Japan) Consortium
中科院分区:
其他
文献类型:
--
作者:
Ferreira IATM;Kemp SA;Datir R;Saito A;Meng B;Rakshit P;Takaori-Kondo A;Kosugi Y;Uriu K;Kimura I;Shirakawa K;Abdullahi A;Agarwal A;Ozono S;Tokunaga K;Sato K;Gupta RK;CITIID-NIHR BioResource COVID-19 Collaboration, Indian SARS-CoV-2 Genomics Consortium;Genotype to Phenotype Japan (G2P-Japan) Consortium

文献摘要

参考文献

被引文献

相似文献

2020年底,印度马哈拉施特拉邦出现了SARS-CoV-2 B.1.617变体。人们一直担心,在受体结合域发现的两个关键突变,L452R和E484Q,会对逃避中和抗体产生叠加效应。我们报道,携带L452R和E484Q的刺突在第一次或第二次接种后对BNT162b2 mRNA疫苗引发的抗体的敏感性略有降低。这种影响与L452R或E484Q单独引起的灵敏度损失的程度相似。这些数据表明L452R和E484Q对疫苗诱导的中和抗体的敏感性降低,但缺乏协同性的敏感性丧失。
The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that 2 key mutations seen in the receptor-binding domain, L452R and E484Q, would have additive effects on evasion of neutralizing antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R or E484Q alone. These data demonstrate reduced sensitivity to vaccine-elicited neutralizing antibodies by L452R and E484Q but lack of synergistic loss of sensitivity.
DOI: 10.1038/s41586-020-2852-1
发表时间: 2020-12
期刊: Nature
影响因子: 64.8
作者:
Barnes CO;Jette CA;Abernathy ME;Dam KA;Esswein SR;Gristick HB;Malyutin AG;Sharaf NG;Huey-Tubman KE;Lee YE;Robbiani DF;Nussenzweig MC;West AP Jr;Bjorkman PJ
通讯作者: Bjorkman PJ
DOI: 10.1371/journal.pone.0050859
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者:
Vermeire J;Naessens E;Vanderstraeten H;Landi A;Iannucci V;Van Nuffel A;Taghon T;Pizzato M;Verhasselt B
通讯作者: Verhasselt B
DOI: 10.1038/s41586-021-03739-1
发表时间: 2021-08
期刊: Nature
影响因子: 64.8
作者:
Collier DA;Ferreira IATM;Kotagiri P;Datir RP;Lim EY;Touizer E;Meng B;Abdullahi A;CITIID-NIHR BioResource COVID-19 Collaboration;Elmer A;Kingston N;Graves B;Le Gresley E;Caputo D;Bergamaschi L;Smith KGC;Bradley JR;Ceron-Gutierrez L;Cortes-Acevedo P;Barcenas-Morales G;Linterman MA;McCoy LE;Davis C;Thomson E;Lyons PA;McKinney E;Doffinger R;Wills M;Gupta RK
通讯作者: Gupta RK
DOI: 10.1016/j.xcrm.2020.100099
发表时间: 2020-09-22
影响因子: 14.3
作者:
Mlcochova, Petra;Collier, Dami;Gupta, Ravindra K.
通讯作者: Gupta, Ravindra K.
DOI: 10.1016/j.celrep.2021.108950
发表时间: 2021-04-06
期刊: Cell reports
影响因子: 8.8
作者:
Rapp M;Guo Y;Reddem ER;Yu J;Liu L;Wang P;Cerutti G;Katsamba P;Bimela JS;Bahna FA;Mannepalli SM;Zhang B;Kwong PD;Huang Y;Ho DD;Shapiro L;Sheng Z
通讯作者: Sheng Z